Clinical trial

QTc Study of Rosi XR in Healthy Volunteers

NCT00884533

Study summary

ClinicalTrials.gov

QTc Study of Rosi XR in Healthy Volunteers

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Rosi XR Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Moxifloxacin Normalized identity: moxifloxacin View linked drug · Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2009-06-01

PhasePHASE1

Conditions

Alzheimer's Diseaseverified · MONDO: Alzheimer disease

Interventions

Rosi XRDRUG

PlaceboOTHER

MoxifloxacinDRUG · verified · RxNorm: moxifloxacin

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

LondonUnited Kingdom1 Overland ParkKansas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00884533 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.